P.P. van der Toorn

546 total citations
6 papers, 378 citations indexed

About

P.P. van der Toorn is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, P.P. van der Toorn has authored 6 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Radiation and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in P.P. van der Toorn's work include Prostate Cancer Diagnosis and Treatment (4 papers), Advanced Radiotherapy Techniques (4 papers) and Prostate Cancer Treatment and Research (4 papers). P.P. van der Toorn is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (4 papers), Advanced Radiotherapy Techniques (4 papers) and Prostate Cancer Treatment and Research (4 papers). P.P. van der Toorn collaborates with scholars based in Netherlands, Italy and United States. P.P. van der Toorn's co-authors include Augustinus D. G. Krol, Wendimagegn Alemayehu, Shafak Aluwini, Erik C. Schimmel, Floris J. Pos, Luca Incrocci, Ben Heijmen, Wilma D. Heemsbergen, Maarten L.P. Dirkx and Coen Hurkmans and has published in prestigious journals such as The Lancet Oncology, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

P.P. van der Toorn

5 papers receiving 368 citations

Peers

Countries citing papers authored by P.P. van der Toorn

Since Specialization

Citations

This map shows the geographic impact of P.P. van der Toorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.P. van der Toorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.P. van der Toorn more than expected).

Fields of papers citing papers by P.P. van der Toorn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.P. van der Toorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.P. van der Toorn. The network helps show where P.P. van der Toorn may publish in the future.

Co-authorship network of co-authors of P.P. van der Toorn

This figure shows the co-authorship network connecting the top 25 collaborators of P.P. van der Toorn. A scholar is included among the top collaborators of P.P. van der Toorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.P. van der Toorn. P.P. van der Toorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Inter-Observer Variation In Tumor Volume Delineation Of Low Grade Gliomas, A Multi-Institutional Contouring Study 2020 ·International Journal of Radiation OncologyBiologyPhysics ·Arnoud V. den Boer, Hiska L. van der Weide, E. Bongers, Ida E.M. Coremans, Daniëlle B. P. Eekers, (unknown), (unknown), (unknown), (unknown), Robert Jan Smeenk, A. J. G. Swaak, P.P. van der Toorn, Joost J.C. Verhoeff, (unknown), Ruud Wiggenraad, Djamal Boukerroui, Johannes A. Langendijk, (unknown), Charlotte L. Brouwer	1
2	Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial 2016 ·The Lancet Oncology ·Shafak Aluwini, Floris J. Pos, Erik C. Schimmel, Augustinus D. G. Krol, P.P. van der Toorn, (unknown), Wendimagegn Alemayehu, Wilma D. Heemsbergen, Ben Heijmen, Luca Incrocci	217
3	A comprehensive evaluation of treatment accuracy, including end-to-end tests and clinical data, applied to intracranial stereotactic radiotherapy 2015 ·Radiotherapy and Oncology ·Enrica Seravalli, P. M. A. van Haaren, P.P. van der Toorn, Coen Hurkmans	31
4	Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial 2015 ·The Lancet Oncology ·Shafak Aluwini, Floris J. Pos, Erik C. Schimmel, (unknown), Augustinus D. G. Krol, P.P. van der Toorn, (unknown), Maarten L.P. Dirkx, Wendimagegn Alemayehu, Ben Heijmen, Luca Incrocci	122
5	Hypofractionated Versus Conventionally Fractionated Radiation Therapy for Prostate Cancer: Five-Year Oncologic Outcomes of the Dutch Randomized Phase 3 HYPRO Trial 2015 ·International Journal of Radiation OncologyBiologyPhysics ·Luca Incrocci, Ruud C. Wortel, Shafak Aluwini, Erik C. Schimmel, Augustinus D. G. Krol, P.P. van der Toorn, (unknown), (unknown), Wendimagegn Alemayehu, Ben Heijmen, Floris J. Pos	6
6	OC-0052: Late toxicity in the randomized phase III Dutch Hypofractionation Trial for prostate cancer patients (HYPRO) 2013 ·Radiotherapy and Oncology ·(unknown), Floris J. Pos, Erik C. Schimmel, (unknown), (unknown), P.P. van der Toorn, (unknown), (unknown), Wendimagegn Ghidey, Luca Incrocci	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact